- Report
- August 2023
- 76 Pages
France
From €2671EUR$2,975USD£2,275GBP
€3142EUR$3,500USD£2,676GBP
- Report
- June 2023
- 73 Pages
United Kingdom
From €2671EUR$2,975USD£2,275GBP
€3142EUR$3,500USD£2,676GBP
- Report
- September 2022
- 114 Pages
Global
From €3434EUR$3,825USD£2,925GBP
€4040EUR$4,500USD£3,441GBP
- Report
- August 2022
- 115 Pages
Global
From €4265EUR$4,750USD£3,632GBP
- Report
- July 2023
- 140 Pages
Global
From €4443EUR$4,949USD£3,784GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2918EUR$3,250USD£2,485GBP
- Report
- October 2023
- 177 Pages
Global
From €3434EUR$3,825USD£2,925GBP
€4040EUR$4,500USD£3,441GBP
- Report
- December 2021
- 120 Pages
Global
From €2245EUR$2,500USD£1,912GBP
- Report
- April 2023
- 115 Pages
Global
From €4265EUR$4,750USD£3,632GBP
- Report
- April 2023
- 120 Pages
Global
From €4265EUR$4,750USD£3,632GBP
- Report
- May 2024
- 200 Pages
Global
From €3726EUR$4,150USD£3,173GBP
- Report
- May 2024
- 200 Pages
Global
From €3726EUR$4,150USD£3,173GBP
- Report
- October 2023
- 146 Pages
Global
From €3726EUR$4,150USD£3,173GBP
- Report
- November 2023
- 115 Pages
Europe
From €3098EUR$3,450USD£2,638GBP
- Report
- November 2023
- 106 Pages
Asia Pacific
From €3098EUR$3,450USD£2,638GBP
- Report
- November 2023
- 96 Pages
North America
From €3098EUR$3,450USD£2,638GBP
- Report
- November 2023
- 96 Pages
Middle East, Africa
From €3098EUR$3,450USD£2,638GBP
- Report
- November 2023
- 94 Pages
From €3098EUR$3,450USD£2,638GBP
- Report
- August 2022
- 330 Pages
Global
From €3995EUR$4,450USD£3,402GBP
- Report
- August 2023
- 215 Pages
Global
From €3995EUR$4,450USD£3,402GBP

A xenograft is a type of biotechnology that involves the transplantation of tissue from one species to another. It is commonly used in medical research and in the development of new treatments for diseases. Xenografts are also used in the production of therapeutic proteins, such as antibodies, and in the production of cell-based therapies.
The xenograft market is a rapidly growing sector of the biotechnology industry. It is driven by the increasing demand for new treatments for diseases, as well as the need for more efficient and cost-effective production of therapeutic proteins and cell-based therapies. The market is also driven by advances in technology, such as gene editing and stem cell research, which have enabled the development of more sophisticated xenografts.
Some of the major companies in the xenograft market include Novartis, Pfizer, Merck, and Amgen. These companies are involved in the development and production of xenografts for medical research and therapeutic applications. Other companies in the market include AbbVie, AstraZeneca, and Regeneron. Show Less Read more